Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.50 Friday, 10th May 2024 AVXL stock ended at $3.81. This is 1.80% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.67% from a day low at $3.75 to a day high of $3.92.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Feb 03, 2020 $2.98 $3.39 $2.97 $3.28 2 591 748
Jan 31, 2020 $2.89 $2.95 $2.80 $2.86 369 575
Jan 30, 2020 $2.96 $2.99 $2.80 $2.89 500 243
Jan 29, 2020 $2.99 $3.08 $2.95 $2.97 301 439
Jan 28, 2020 $2.97 $3.08 $2.95 $2.98 454 707
Jan 27, 2020 $2.80 $2.97 $2.76 $2.93 628 232
Jan 24, 2020 $3.00 $3.03 $2.86 $2.92 543 199
Jan 23, 2020 $3.06 $3.09 $2.91 $2.99 694 596
Jan 22, 2020 $3.19 $3.21 $3.00 $3.06 633 436
Jan 21, 2020 $3.37 $3.39 $3.11 $3.17 843 876
Jan 17, 2020 $3.20 $3.40 $3.15 $3.30 1 029 432
Jan 16, 2020 $3.06 $3.20 $3.03 $3.17 792 199
Jan 15, 2020 $3.07 $3.07 $2.95 $3.02 697 704
Jan 14, 2020 $3.07 $3.14 $2.93 $2.96 756 045
Jan 13, 2020 $3.00 $3.23 $3.00 $3.10 1 045 976
Jan 10, 2020 $2.96 $3.02 $2.86 $2.99 798 163
Jan 09, 2020 $2.93 $3.06 $2.85 $2.88 869 970
Jan 08, 2020 $2.96 $2.98 $2.74 $2.85 992 979
Jan 07, 2020 $2.97 $2.99 $2.77 $2.90 635 691
Jan 06, 2020 $2.65 $3.00 $2.63 $2.96 1 243 869
Jan 03, 2020 $2.78 $2.78 $2.55 $2.65 859 771
Jan 02, 2020 $2.63 $2.88 $2.57 $2.87 1 063 395
Dec 31, 2019 $2.36 $2.59 $2.36 $2.59 539 892
Dec 30, 2019 $2.55 $2.57 $2.35 $2.36 832 656
Dec 27, 2019 $2.84 $2.90 $2.51 $2.54 1 022 265
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT